Intravenous Equipment Market

Intravenous (IV) Equipment Market Outlook (2025 to 2035)

The global intravenous (IV) equipment market was valued at US$ 18,774 million in 2024 and has been forecasted to expand at a noteworthy CAGR of 5.9% to end up at US$ 35,270 million by 2035.

The worldwide intravenous (IV) equipment sector provides a collection of medical devices and consumable products which allow direct bloodstream delivery of fluids and medications and nutrients to patients. IV equipment includes various fundamental elements of catheters, administration sets, infusion pumps, stopcocks, check valves and needleless connectors and securement devices and drip chambers.

These vital delivery tools function in all healthcare facilities starting from hospitals up to specialty clinics and extending to home care and ambulatory care centers to facilitate controlled substance administration. The IV equipment market expands because of mounting healthcare challenges alongside technological developments specifically targeted at elderly patient groups.

Report Attributes	Details
Intravenous (IV) Equipment Market Size (2024A)	US$ 18,774 Million
Estimated Market Value (2025E)	US$ 19,881 Million
Forecasted Market Value (2035F)	US$ 35,2670 Million
Global Market Growth Rate (2025 to 2035)	5.9% CAGR
East Asia Market Share (2025)	19.8%
China Market Growth Rate (2025 to 2035)	68.7% CAGR
Key Companies Profiled	Braun Melsungen AG; 3M; Terumo Corporation; Abbott; Teleflex Incorporated; BD; Henry Schein, Inc.; Smiths Medical; Baxter.; Ascor S.A.; Moog Inc.; AngioDynamics.; ICU Medical, Inc.; Fresenius SE & Co. KGaA; Animas LLC; arcomed ag; International WIN, LTD.; The Metrix Company; Other Prominent Players.

Historic Analysis (2020 to 2024) and Future (2025 to 2035) Pathway Analysis for the intravenous (IV) equipment market

Significant expansion of the IV equipment market took place between 2020 and 2024 because the numbers of people diagnosed with diabetes along with cancer and cardiovascular diseases continued to rise. The market expanded because smart infusion pumps and needleless connectors enhanced patient protection and treatment outcomes through technological developments.

• Short Term (2025 to 2028): The market will maintain a positive trend during 2025 to 2027 because of modern advancements in IV equipment technology. The implementation of wireless connectivity and data analytics in infusion pumps enhances tracking functionality and accuracy which decreases medical errors between treatments. Home healthcare service adoption growth will enhance market demand for easy-to-use IV devices because patients prefer low-cost treatment options outside hospital settings.
• Medium Term (2029 to 2031): The market will grow through healthcare infrastructure expansion in developing economies during Medium Term (2028 to 2030). Government programs focused on healthcare expansion will drive an increased purchase of IV equipment by healthcare facilities. The market will experience additional growth because the increasing number of chronic diseases requires widespread intravenous therapy administration in these regions.
• Long Term (2032 to 2035): Between 2031 to 2035 the market will focus on sustainable and eco-friendly IV equipment development to handle medical waste challenges. Actions in materials science research will develop recyclable components that follow international sustainability targets. The growing field of personalized medicine will increase market demand for patient-specific IV solutions which enhance therapeutic results.

On the back of the aforementioned facts, the Intravenous (IV) Equipment market is anticipated to grow at a CAGR of 5.9% during the forecast period from 2025 to 2035, According to the Fact.MR, a market research and competitive intelligence provider.

Market Dynamics

What Impact does the Escalating Occurrence of Chronic Diseases Create on the Market Expansion of Intravenous Equipment?

The rising numbers of people affected by diabetes and cancer and heart diseases create strong market demand for intravenous equipment systems. Patients with these medical conditions need extended periods of intravenous care delivery for drug dosing as well as hydration and nutritional feeding. IV infusion chemotherapy needed for cancer patients depends on reliable and efficient intravenous devices for delivery.

Critical medical conditions involving severe diabetes demand intravenous injection of insulin as a standard therapeutic approach. The increasing prevalence of these diseases due to aging populations and sedentary lifestyles and unhealthy diets drives health facilities to admit more patients to care for through IV therapy treatment protocols. Market expansion occurs because medical facilities purchase state-of-the-art intravenous equipment to provide better healthcare and achieve superior treatment results.

“Technological Growth cause the IV Equipment Market to Extend”

Technical advances directly propel the growth of the IV equipment market through safe and efficient intravenous therapy systems which are user-friendly for healthcare providers. Patient care improved significantly due to the introduction of smart infusion pumps that include dose error reduction systems along with wireless connectivity and real-time monitoring functions.

The safe delivery of medicines results from these modern systems because they prevent administration mistakes and enable medical professionals to conduct distant monitoring sessions and record infusion information directly to electronic patient files.

The implementation of needleless connectors has lowered the chance of healthcare worker injuries looking for a portal to draw blood together with the risks of infections which protects patients and medical staff from harm. New advancements in catheter materials and their designs have produced durable products which minimize patient discomfort during use.

These technological developments create more attraction to IV equipment which leads healthcare establishments to upgrade existing infrastructure and acquire modern solutions for market expansion.

The Expensive Nature of High-tech IV Equipment Generates Obstacles toward Market Advancement??

“Technology Comes with a Cost”

Advanced IV equipment pricing acts as a major hurdle for market expansion mainly because of its expense in resource-environment where funds are limited. State-of-the-art infusion pumps together with closed-system transfer devices provide better efficiency and security although they require high initial expenses. Healthcare facilities located mainly in developing countries find it challenging to finance these investments therefore they operate with older or less efficient equipment.

High maintenance and training expenses related to advanced IV systems act as barriers for adoption because they prove difficult to afford. The high financial costs prevent wide adoption of advanced IV technologies thus endangering patient care standards and safety levels.

The availability of advanced IV equipment must increase through collaboration between manufacturers and regulation-makers who establish funding solutions to reach healthcare settings that need more effective medical instrumentation.

Country-wise Insights

Why is Adoption of Intravenous (IV) Equipment High in the United States?

“Advanced Healthcare Facilities across the United States drive Market Changes in IV Equipment Products”

The market in the United States is estimated at US$ 6,073.8 million in 2025 and is projected to expand at a CAGR of 6.5% through 2035. This market is projected to generate a US$ 5,357.2 million absolute opportunity from 2025 to 2035.

The United States maintains an advanced healthcare system built from state-of-the-art medical facilities with regulatory standards and extensive healthcare costs. The state-of-the-art medical technology enables easy integration of modern IV equipment technologies by healthcare facilities through its advanced systems framework. The presence of leading medical device manufacturers and research institutions in the U.S. fosters continuous innovation and availability of cutting-edge IV equipment.

The established insurance coverage for intravenous therapies and reimbursement policies lead healthcare providers to adopt advanced IV equipment for delivering top-quality patient care. Safety practices and technological development together with leading medical producers and research facilities make the United States an influential market force in global IV equipment markets.

Why is China a Lucrative Market for IV Equipment Manufacturers?

“The continuous growth of China's healthcare facilities shapes the market dynamics for IV equipment”

The Chinese healthcare sector maintains rapid expansion through government-backed initiatives including Healthy China 2030 Plan which works to enhance medical access and services quality. Public Hospital expansion and technological innovations across medical services and educational development programs result in enhanced demand for IV equipment throughout China. New hospital openings and existing facility upgrades drive infusion pump and catheter and administration set usage rates higher within healthcare institutions.

China strengthened its position as a major producer and consumer of IV equipment by means of government policies which support medical device manufacturing in the local market. The IV equipment market maintains an upward trajectory because medical facilities choose automated digital solutions which will particularly benefit urban hospitals along with speciality clinics.

The Chinese population is rapidly aging which places China among the nations with the fastest-growing aging demographic because estimates project that by 2035 there will be more than 400 million people who are at least sixty years old. The aging population trends serve as the main contributor to higher hospitalization numbers and long-term care requirements which depend heavily on IV treatment methods.

Chinese patients diagnosed with age-related diseases such as cardiovascular conditions and diabetes and cancer require frequent intravenous treatments which generates growing demand for IV catheters combined with infusion pumps and securement devices.

The rising trend of home healthcare in China promotes the use of portable IV equipment that providers find easy to operate. Public entities are working to improve elder care centers because of an extended demand forecast for IV therapy solutions within the upcoming years.

Category-wise Insights

Why do IV Catheters Hold the Largest Share in the Global IV Equipment Market?

“The global IV equipment market indicates that IV Catheters maintain the lead position as far as market share is concerned”

Demand for IV Catheters is projected to increase at a CAGR of 5.7% from 2025 to 2035. The segment holds 28.1% market share in the global market in 2025. The market for intravenous equipment is controlled by IV catheters which account for approximately 35% market share due to their essential function in drug delivery transactions alongside fluid resuscitation and transfusions throughout healthcare facilities.

The complete dependence of hospitals and specialty clinics on IV catheters exists for both urgent and sustaining patient treatments. Higher demand for IV catheterization emerges from the expanding cases of chronic diseases and surgical procedures together with cancer treatments in healthcare facilities.

The adoption of IV catheters continues to rise because safety catheters and closed IV catheter systems have proven effective in reducing infections while promoting patient safety measures. The three leading producers BD (Becton, Dickinson and Company), B. Braun Melsungen, and Smiths Medical dedicate their work to developing better catheters and insertion procedures to stop phlebitis and bloodstream infections.

The advancement of minimally invasive medical procedures is one factor that strengthened the market demand for IV catheters. Rapid healthcare access expansion alongside increasing hospital patient numbers across Asia-Pacific and Latin American regions is fueling IV catheter market dominance due to enhanced healthcare access during this period of rapid market development.

Why Does Hospitals Account for Extensive Use of Intravenous (IV) Equipment?

“Hospitals serve as the principal consumer group that purchases IV equipment”

Hospitals are estimated to account for 56.2% share of the market in 2025. The intravenous (IV) equipment market shows hospitals having the biggest segment (60%) because they receive numerous patients along with their sophisticated healthcare infrastructure and ample utilization of IV treatments.

Medical facilities need uninterrupted supplies of intravenous catheters as well as infusion pumps and administration sets and securement devices to enable surgery support and emergency care and inpatient medical treatments.

The escalating number of patients requiring hospital care because of diabetes and cardiovascular diseases and cancer drives up demand for intravenous equipment. ICUs and EDs need IV therapy at all times to handle fluids simultaneously with medications and nutritional supplies.

The surge in surgical procedures together with chemotherapy administration demands hospitals to adopt dependable sterile IV equipment for controlling hospital-acquired infections (HAIs). The improvement of healthcare infrastructure through government programs within developing regions leads to increased purchasing of IV equipment.

Large hospital facilities take advantage of buying in bulk from manufacturers to acquire lower-priced supplies. Hospitals remain the primary market segment within this sector since they continue their investments in advanced IV devices under patient safety and infection control initiatives.

Competitive Landscape

Key players in the intravenous (IV) equipment market are Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein, Inc., Smiths Medical, Baxter International, Ascor S.A., Moog Inc., AngioDynamics., ICU Medical, Inc., Fresenius SE & Co. KgaA, Animas LLC, arcomed ag, International WIN, LTD., The Metrix Company.

Companies devote a significant portion of their revenue to R&D to resolve problems and offer creative solutions to draw in new customers and stay competitive. Companies are developing customized offerings for issues that meet industry-specific needs to compete with other players.

• BD (Becton, Dickinson and Company) Expands IV Solutions Portfolio (January 2024) - The company made a move to increase its IV catheters and infusion set offerings while concentrating on infection prevention systems and patient safety enhancements. BD (Becton, Dickinson and Company) launched a next-gen closed IV catheter system intended to diminish bloodstream infections.
• B. Braun Launches Smart Infusion Pump with AI Integration (December 2023) - A new B. Braun series of AI-enabled smart infusion pumps reached the market to deliver higher safety standards across medication delivery functions. The system achieves two main objectives by uniting with electronic health records (EHRs) which helps prevent errors while increasing treatment performance.

Fact.MR has provided detailed information about the price points of key manufacturers of intravenous (IV) equipment positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Intravenous (IV) Equipment Industry Research

• By Type :

  • IV Catheters
  • Infusion Pumps
  • Securement Devices
  • Stopcocks & Check Valves
  • Administration Sets
    • Solution Administration Sets
    • Blood Administration Sets
  • Drip Chambers
  • Needleless Connectors
  • Other IV Equipments

• By End User :

  • Hospitals
  • Specialty Clinics
  • Academic & Research Institutes
  • Home Care
  • Ambulatory Care Centers

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa